This trial hypothesizes that the combination of zidovudine and nevirapine (NVP) will more effectively lower maternal-infant transmission than zidovudine alone. This is a Phase III, randomized, double-blind study of NVP administered to pregnant HIV-infected women during labor, and to their infants between 48 and 72 hours of age. The primary endpoint is the incidence of HIV transmission from mother to infant. The study will also evaluate the following: a) Safety and tolerance of oral NVP in pregnant HIV-infected women and HIV-exposed infants, b) NVP pharmacokinetics (PK) in a large population of neonates, c) Impact of maternal medications on neonatal NVP PK parameters, d) Relationship between maternal viral load at delivery and HIV transmission, and e) Effect of NVP on HIV RNA levels in infants determined to be HIV-infected. Women will be randomized to receive either a single 200 mg oral dose of NVP or the corresponding placebo during labor. They will be randomized at any time after their 28th week of gestation and they will be followed for 4-6 weeks postpartum. Infants will receive a single 2 mg/kg oral dose of NVP or corresponding placebo administered between 48 and 72 hours of life. The infant's study drug will be the same as the mother's randomized treatment assignment. Infants will be followed for 6 months and will be tested for HIV at 4 to 6 weeks and at 3 and 6 months of life.
| AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786 |
| Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671 |
| Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72 |
| Al-Sofiani, Mohammed E; Yanek, Lisa R; Faraday, Nauder et al. (2018) Diabetes and Platelet Response to Low-Dose Aspirin. J Clin Endocrinol Metab 103:4599-4608 |
| Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429 |
| Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451 |
| Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504 |
| Aboud, Katherine S; Barquero, Laura A; Cutting, Laurie E (2018) Prefrontal mediation of the reading network predicts intervention response in dyslexia. Cortex 101:96-106 |
| Kattan, Meyer; Bacharier, Leonard B; O'Connor, George T et al. (2018) Spirometry and Impulse Oscillometry in Preschool Children: Acceptability and Relationship to Maternal Smoking in Pregnancy. J Allergy Clin Immunol Pract 6:1596-1603.e6 |
| Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521 |
Showing the most recent 10 out of 1014 publications
